Should atelectasis be considered a pulmonary complication and indicator of poor prognosis in cystic fibrosis?
- PMID: 38546237
- PMCID: PMC10981250
- DOI: 10.1177/03000605241233520
Should atelectasis be considered a pulmonary complication and indicator of poor prognosis in cystic fibrosis?
Abstract
Objective: This study examined whether bronchoscopy leads to clinicoradiological improvement in cystic fibrosis (CF) and the predictive factors. The study also investigated whether pulmonary atelectasis is a poor prognostic factor in CF.
Methods: This multicenter, case-control, observational, retrospective study included two groups of patients with CF: a case group (patients with persistent atelectasis who were followed-up at least for 2 years) and a control group (patients without atelectasis matched 1:1 by sex and age [±3 years]). We recorded demographic data, lung function test results, pulmonary complications, comorbidities, treatments (including bronchoscopies, surgery and transplantation), and deaths.
Results: Each group included 55 patients (case group: 20 men, mean age 25.4 ± 10.4 years; control group: 20 men, mean age 26.1 ± 11.4 years). Bronchoscopy did not lead to clinicoradiological improvement. Allergic bronchopulmonary aspergillosis (ABPA) was more frequent in the case group. Patients in the case group more frequently used inhaled steroids, their pre-atelectasis lung function was statistically worse, and they had more exacerbations during follow-up.
Conclusion: Moderate-to-severe pulmonary disease and ABPA can favor atelectasis. Pulmonary atelectasis can be a poor prognostic factor in CF because it increases exacerbations. Despite our results, we recommend enhancing treatment, including bronchoscopy, to prevent persistent atelectasis.
Keywords: Cystic fibrosis; allergic bronchopulmonary aspergillosis; atelectasis; bronchoscopy; exacerbation; prognosis; risk factor.
Conflict of interest statement
Declaration of conflicting interestThe authors declare that there are no conflicts of interest.
Figures
Similar articles
-
The clinical presentations of pulmonary aspergillosis in children with cystic fibrosis - preliminary report.Dev Period Med. 2015 Jan-Mar;19(1):66-79. Dev Period Med. 2015. PMID: 26003072
-
Total unilateral pulmonary collapse secondary to allergic bronchopulmonary aspergillosis: a case series of an unusual cause of complete atelectasis.BMC Pulm Med. 2021 Dec 24;21(1):425. doi: 10.1186/s12890-021-01789-9. BMC Pulm Med. 2021. PMID: 34952578 Free PMC article.
-
Allergic bronchopulmonary aspergillosis is associated with pet ownership in cystic fibrosis.Pediatr Allergy Immunol. 2016 Sep;27(6):597-603. doi: 10.1111/pai.12590. Epub 2016 Jun 1. Pediatr Allergy Immunol. 2016. PMID: 27145047
-
[Allergic Broncho-Pulmonary Aspergillosis (ABPA) in cystic fibrosis: Mechanisms, diagnosis and therapeutic options].Rev Mal Respir. 2021 May;38(5):466-476. doi: 10.1016/j.rmr.2021.04.004. Epub 2021 Apr 27. Rev Mal Respir. 2021. PMID: 33926779 Review. French.
-
Allergic bronchopulmonary aspergillosis in two patients with cystic fibrosis.Turk J Pediatr. 2000 Jan-Mar;42(1):68-71. Turk J Pediatr. 2000. PMID: 10731875 Review.
References
-
- Lerín M, Prados C, Martínez MT, et al.. Cystic fibrosis in adult age. Rev Clin Esp (Barc) 2014; 214: 289–295. - PubMed
-
- Huisman C, De Graaff CS, Boersma WG. Unilateral air bronchogram in a patient with cystic fibrosis. Chest 2002; 121: 1343–1344. - PubMed
-
- Martínez Redondo M, Prados Sánchez C, Salcedo Posadas A, et al.. Características de las atelectasias como complicación pulmonar en la fibrosis quística. Rev Patol Respir 2017; 20: 79–87.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical